NTI Ann: NTI Receives HREC/TGA Approval for Phase II/III ASD Trial - 17th Nov 2022, 9:20am

annb0t

annb0t

Top 20
NTI Ann: NTI Receives HREC/TGA Approval for Phase II/III ASD Trial
Price Sensitive: Y
Date: 17th Nov 2022, 9:20am

>>> Read announcement: Google: NTI Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
NTI Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 27th Oct 2023, 8:08am
Replies
0
Views
56
annb0t
annb0t
annb0t
NTI Ann: Notice of Quarterly Investor Conference Call - 24th Oct 2023, 11:52am
Replies
0
Views
61
annb0t
annb0t
annb0t
NTI Ann: Notice of Annual General Meeting/Proxy Form - 16th Oct 2023, 1:25pm
Replies
0
Views
75
annb0t
annb0t
annb0t
NTI Ann: Investor Presentation - PANDAS/PANS Clinical Trials Results - 6th Oct 2023, 11:33am
Replies
0
Views
82
annb0t
annb0t
annb0t
NTI Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint - 6th Oct 2023, 9:25am
Replies
0
Views
64
annb0t
annb0t
Top Bottom